Are Mentalizing Abilities and Insight Related to the Severity of Obsessive-Compulsive Disorder

키워드

참고문헌 (86)

1. Stein DJ, "Obsessive-compulsive disorder", Lancet, 360, pp.397~405 (2002)
2. Jenike MA, "Obsessive-compulsive disorder", N Engl J Med, 350, pp.259~265 (2004)
3. Pallanti S, "Emerging drugs to treat obsessive-compulsive disorder", Expert Opin Emerg Drugs, 19, pp.67~77 (2014)
4. Bloch MH, "A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder", Mol Psychiatry, 11, pp.622~632 (2006)
5. Khalsa SS, "Treatment-resistant OCD: options beyond first-line medications", Curr Psychiatry, 10, pp.44~52 (2011)
6. Pallanti S, "Treatment non-response in OCD: methodological issues and operational definitions", Int J Neuropsychopharmacol, 5, pp.181~191 (2002)
7. Hollander E, "Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study", Int J Neuropsychopharmacol, 6, pp.397~401 (2003)
8. Albert U, "Treatment-resistant obsessive-compulsive disorder (OCD): current knowledge and open questions", Clin Neuropsychiatry, 10, pp.19~30 (2013)
9. Alonso P, "Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy", J Clin Psychiatry, 62, pp.535~540 (2001)
10. Ackerman DL, "Side effects as predictors of drug response in obsessive-compulsive disorder", J Clin Psychopharmacol, 19, pp.459~465 (1999)
11. Erzegovesi S, "Clinical predictors of drug response in obsessive-compulsive disorder", J Clin Psychopharmacol, 21, pp.488~492 (2001)
12. 김찬형, "Clinical Predictors of Drug Response in Patients with Obsessive-Compulsive Disorder", Clinical Psychopharmacology and Neuroscience, 9(1), pp.23~28 (2011), 대한정신약물학회
13. Semiz UB, "Are trauma and dissociation related to treatment resistance in patients with obsessive-compulsive disorder?", Soc Psychiatry Psychiatr Epidemiol, 49, pp.1287~1296 (2014)
14. Maltby N, "Overview of treatments for obsessive-compulsive disorder and spectrum conditions: conceptualization, theory, and practice", Br Treat Cris Interv, 3, pp.127~144 (2003)
15. Marazziti D, "Current pharmacological and non pharmacological treatments for obsessive-compulsive disorder", J Psychopathol, 18, pp.5~18 (2012)
16. Koran LM, "Practice Guideline for the treatment of patients with obsessive-compulsive disorder", Am J Psychiatry, 64(7 suppl), pp.5~53 (2007)
17. Kishore VR, "Clinical characteristics and treatment response in poor and good insight obsessive-compulsive disorder", Eur Psychiatry, 19, pp.202~208 (2004)
18. Shetti CN, "Clinical predictors of drug nonresponse in obsessive-compulsive disorder", J Clin Psychiatry, 66, pp.1517~1523 (2005)
19. Hantouche EG, "Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study", Encephale, 26, pp.73~83 (2000)
20. Catapano F, "Insight and resistance in patients with obsessive-compulsive disorder", Psychopathology, 34, pp.62~68 (2001)
21. Matsunaga H, "Obsessive-compulsive disorder with poor insight", Compr Psychiatry, 43, pp.150~157 (2002)
22. Ng R, "Insight and theory of mind in schizophrenia", Psychiatry Res, 225, pp.169~174 (2015)
23. Frith U, "Autism: beyond theory of mind", Cognition, 50, pp.115~132 (1994)
24. Frith C, "Theory of mind", Curr Biol, 15, pp.R644~R645 (2005)
25. Ntouros E, "Emotional perception and theory of mind in first episode psychosis: the role of obsessive-compulsive symptomatology", Psychiatry Res, 220, pp.112~117 (2014)
26. Darvishi N, "Theory of mind in obsessive-compulsive disorder patients versus normal individuals", Adv Cogn Sci, 15, pp.77~89 (2013)
27. Islam L, "First- and third-person perspectives in psychotic disorders and mood disorders with psychotic features", Schizophr Res Treatment, 2011, pp.769136~ (2011)
28. Lysaker PH, "Metacognition amidst narratives of self and illness in schizophrenia: Associations with neurocognition, symptoms, insight and quality of life", Acta Psychiatr Scand, 112, pp.64~71 (2005)
29. Fonagy P, "Affect Regulation, Mentalization and the Development of the Self" (2004), Karnac Books
30. Bateman AW, "Handbook of Mentalizing in Mental Health Practice" (2012), American Psychiatric Pub
31. Sayin A, "Theory of mind in obsessive-compulsive disorder: comparison with healthy controls", Eur Psychiatry, 25, pp.116~122 (2010)
32. Kang JI, "Abnormalities of emotional awareness and perception in patients with obsessive-compulsive disorder", J Affect Disord, 141, pp.286~293 (2012)
33. Grisham JR, "Compulsive hoarding: current controversies and new directions", Dialogues Clin Neurosci, 12, pp.233~240 (2010)
34. David AS, ""To see oursels as others see us". Aubrey Lewis's insight", Br J Psychiatry, 175, pp.210~216 (1999)
35. Bora E, "Theory of mind and unawareness of illness in schizophrenia: is poor insight a mentalizing deficit?", Eur Arch Psychiatry Clin Neurosci, 257, pp.104~111 (2007)
36. Langdon R, "Taking the perspective of the other contributes to awareness of illness in schizophrenia", Schizophr Bull, 35, pp.1003~1011 (2009)
37. First MB, "Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)" (1997), American Psychiatric Press
38. Goodman WK, "The Yale-Brown Obsessive Compulsive Scale: I. development, use, and reliability", Arch Gen Psychiatry, 46, pp.1006~1011 (1989)
39. Tek C, "Yale-Brown Obsessive Compulsive Scale and US National Institute of Mental Health Global Obsessive Compulsive Scale in Turkish: reliability and validity", Acta Psychiatr Scand, 91, pp.410~413 (1995)
40. Hisli Sahin N, "A study on the validity of Beck Depression Inventory in Turkish", Turkish J Psychol, 7, pp.3~13 (1988)
41. Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
42. Beck AT, "An inventory for measuring clinical anxiety: psychometric properties", J Consult Clin Psychol, 56, pp.893~897 (1988)
43. Ulusoy M, "Turkish version of the Beck Anxiety Inventory: psychometric properties", J Cogn Psychother An Int Q, 12, pp.163~172 (1998)
44. Baron-Cohen S, "The "Reading the Mind in the Eyes" Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism", J Child Psychol Psychiatry, 42, pp.241~251 (2001)
45. Yildirim EA, "Investigation of the reliability of the "reading the mind in the eyes test" in a Turkish population", Turk Psikiyatr Derg, 22, pp.177~186 (2011)
46. Eisen JL, "The brown assessment of beliefs scale: reliability and validity", Am J Psychiatry, 155, pp.102~108 (1998)
47. Ozcan T, "Brown assessment of beliefs scale: a study of reliability and validity", J Cogn Psychother Res, 2, pp.25~33 (2013)
48. Stewart SL, "The relationship between theory of mind and insight in psychosis: evidence for specificity", Psychosis, 2, pp.34~40 (2010)
49. Quee PJ, "Insight change in psychosis: relationship with neurocognition, social cognition, clinical symptoms and phase of illness", Acta Psychiatr Scand, 129, pp.126~133 (2014)
50. Catapano F, "Obsessive-compulsive disorder with poor insight: a three-year prospective study", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.323~330 (2010)
51. Solyom L, "Is there an obsessive psychosis? Aetiological and prognostic factors of an atypical form of obsessive-compulsive neurosis", Can J Psychiatry, 30, pp.372~380 (1985)
52. Prasko J, "Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder", Neuroendocrinol Lett, 30, pp.615~623 (2009)
53. Eisen JL, "Insight in obsessive compulsive disorder and body dysmorphic disorder", Compr Psychiatry, 45, pp.10~15 (2004)
54. Alonso P, "Clinical implications of insight assessment in obsessive-compulsive disorder", Compr Psychiatry, 49, pp.305~312 (2008)
55. Lelliott PT, "Obsessive-compulsive beliefs and treatment outcome", Psychol Med, 18, pp.697~702 (1988)
56. Ito LM, "Beliefs and resistance in obsessive-complulsive disorder: observations from a controlled study", J Anxiety Disord, 9, pp.269~281 (1995)
57. Steketee G, "Predicting behavioral treatment outcome for agoraphobia and obsessive compulsive disorder", Clin Psychol Rev, 15, pp.317~346 (1995)
58. Turksoy N, "Comparison of clinical characteristics in good and poor insight obsessive-compulsive disorder", J Anxiety Disord, 16, pp.413~423 (2002)
59. Bellino S, "Clinical picture of obsessive-compulsive disorder with poor insight: a regression model", Psychiatry Res, 136, pp.223~231 (2005)
60. Samuels J, "Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD collaborative genetics study", Am J Psychiatry, 164, pp.493~499 (2007)
61. Saxena S, "Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment", J Clin Psychiatry, 63, pp.21~27 (2002)
62. Altintas E, "Factors associated with depression in obsessive-compulsive disorder: a cross-sectional study", Noropsikiyatri Ars, 52, pp.346~353 (2015)
63. Butler G, "Cognitive processes in anxiety", Adv Behav Res Ther, 5, pp.51~62 (1983)
64. Pigott TA, "Pharmacotherapy of obsessive-compulsive disorder", Int Rev Psychiatry, 9, pp.133~147 (1997)
65. De Berardis D, "Insight and alexithymia in adult outpatients with obsessive-compulsive disorder", Eur Arch Psychiatry Clin Neurosci, 255, pp.350~358 (2005)
66. Jakubovski E, "Dimensional correlates of poor insight in obsessive-compulsive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 35, pp.1677~1681 (2011)
67. Elvish J, "Which clinical and demographic factors predict poor insight in individuals with obsessions and", or compulsions?, 2010, pp.24, 231~237
68. Fornaro M, "Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report", Ann Gen Psychiatry, 7, pp.26~ (2008)
69. Szechtman H, "Obsessive-compulsive disorder as a disturbance of security motivation", Psychol Rev, 111, pp.111~127 (2004)
70. Cherian AV, "Does insight have specific correlation with symptom dimensions in OCD?", J Affect Disord, 138, pp.352~359 (2012)
71. Kumar H, "Symptom dimensions and clinical presentations in obsessive compulsive disorder", Int J Indian Psychol, 59, pp.116~ (2016)
72. Gubb K, "Psychosomatics today: a review of contemporary theory and practice", Psychoanal Rev, 100, pp.103~143 (2013)
73. Drake RJ, "Insight and neurocognition in schizophrenia", Schizophr Res, 62, pp.165~173 (2003)
74. Harrington L, "Theory of mind in schizophrenia: a critical review", Cogn Neuropsychiatry, 10, pp.249~286 (2005)
75. Bateman A, "8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual", Am J Psychiatry, 165, pp.631~638 (2008)
76. Bateman A, "Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder", Am J Psychiatry, 166, pp.1355~1364 (2009)
77. Fett AKJ, "The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis", Neurosci Biobehav Rev, 35, pp.573~588 (2011)
78. Bodden ME, "Comparing the neural correlates of affective and cognitive theory of mind using fMRI: involvement of the basal ganglia in affective theory of mind", Adv Cogn Psychol, 9, pp.32~43 (2013)
79. Miguel EC, "Obsessive-compulsive disorder", Psychiatr Clin North Am, 20, pp.863~883 (1997)
80. Maia AS, "Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia", Rev Hosp Clin Fac Med Sao Paulo, 54, pp.213~221 (1999)
81. Di Matteo V, "Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders", Prog Brain Res, 172, pp.423~463 (2008)
82. Assogna F, "The recognition of facial emotion expressions in Parkinson's disease", Eur Neuropsychopharmacol, 18, pp.835~848 (2008)
83. Tas C, "Experimental Usage of Oxytocin to Combat Deficits in Social Cognition in Schizophrenia;Social Cognition and Metacognition in Schizophrenia: Psychopathology and Treatment Approaches", pp.2014, Academic Press
84. Brent BK, "A mentalization-based approach to the development of the therapeutic alliance in the treatment of schizophrenia", J Clin Psychol, 71, pp.146~156 (2015)
85. Humble MB, "Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study", BMC Psychiatry, 13, pp.344~ (2013)
86. Oakley BFM, "Theory of mind is not theory of emotion: a cautionary note on the reading the mind in the eyes test", J Abnorm Psychol, 125, pp.818~823 (2016)

관련 논문AI추천